Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) appears in 99 institutional 13F filings for the quarter ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 31 Mar, 2026 | 10,563,103 | -2,375,718 | -18.36% | $22,500.00 |
| NEA Management Company, LLC | 31 Mar, 2026 | 4,448,757 | 0 | 0.00% | $9,475,852.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 2,348,651 | 718,478 | 44.07% | $4,997.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 1,643,747 | 694,012 | 73.07% | $3,501,181.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 1,301,664 | 444,649 | 51.88% | $2,772,069.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 1,106,840 | 218,580 | 24.61% | $2,357,570.00 |
| Connor, Clark & Lunn Investment Management Ltd. | 31 Mar, 2026 | 1,058,397 | 403,698 | 61.66% | $2,254,386.00 |
| MACKENZIE FINANCIAL CORP | 31 Mar, 2026 | 844,835 | 492,381 | 139.70% | $1,799,499.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 836,266 | -273,822 | -24.67% | $1,781,245.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Mar, 2026 | 834,570 | -205,898 | -19.79% | $1,777,634.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 723,477 | 550,177 | 317.47% | $1,541,006.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 684,418 | 33,764 | 5.19% | $1,457,811.00 |
| FMR LLC | 31 Mar, 2026 | 623,827 | 82,673 | 15.28% | $1,328,751.00 |
| UBS Group AG | 31 Mar, 2026 | 564,838 | 307,205 | 119.24% | $1,203,105.00 |
| Man Group plc | 31 Mar, 2026 | 559,700 | 429,667 | 330.43% | $1,192,161.00 |
| WINTON GROUP Ltd | 31 Mar, 2026 | 538,259 | 116,979 | 27.77% | $1,146,492.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 536,575 | 30,795 | 6.09% | $1,143,769.00 |
| AWM Investment Company, Inc. | 31 Mar, 2026 | 525,000 | -100,000 | -16.00% | $1,118,250.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 510,811 | 510,811 | 0.00% | $1,088,027.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 502,652 | 77,193 | 18.14% | $1,070,649.00 |